Analyst Models NeurAxis 12-Month Share Price Target At $14, 301% Higher Than Current Price ($NRXS)
Having just 1.21 million outstanding shares typically presents exceptionally well to a growth stock investor. But while it can fuel appreciable gains quickly, it can also cause downward pressure....
United States Brian Carrico Jack Enterprises Neuraxis Inc Boston Scientific Corp Goldman Small Cap Research
Source: marketscreener.com